Osteopore Limited (ASX:OSX)

Market Cap	2.43M
Revenue (ttm)	2.76M
Net Income (ttm)	-3.35M
Shares Out	173.43M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,320,350
Average Volume	1,108,074
Open	0.0130
Previous Close	0.0140
Day's Range	0.0130 - 0.0150
52-Week Range	0.0120 - 0.1000
Beta	-0.25
RSI	42.31
Earnings Date	May 30, 2025

About Osteopore

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company manufactures and trades medical impl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2003
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OSX

Financial Performance

In 2024, Osteopore's revenue was 2.76 million, an increase of 24.60% compared to the previous year's 2.22 million. Losses were -3.35 million, -31.19% less than in 2023.